TRU
-
Anti-trust authorities approve Bosch’s acquisition of Eisai Machinery
Bosch finalized the acquisition of the machinery business companies of Eisai, one of the leading Japanese pharmaceutical companies based in Tokyo. The transaction has been approved by the antitrust authorities without further restrictions.
TRU | 14 May 2012
-
Bosch launches integrated pharmaceutical melt extrusion and calendering line
Bosch Packaging Technology presents its fully integrated pharmaceutical melt extrusion and calendering line featuring a continuous production process for pharmaceutical substances. Melt extrusion as a drug production method is growing in popularity due to its ability to improve drug delivery effectiveness. Using this technology, poorly soluble drugs with low bioavailability can be administered in tablet or granulate formats. Efficient production and cost savings are additional benefits as there is no need for additives such as solvents or drying processes.
TRU | 07 December 2011
-
Small molecule structural elucidation software
Thermo Fisher Scientific released the Mass Frontier 7.0, its small molecule structural elucidation software. The software simplifies the management, evaluation and interpretation of mass spectral data and can be used for metabolism, metabolomics, fo…
TRU | 10 December 2010
-
T-rex: refractive index detection instrument
Wyatt Technology announces the launch of its Refractive Index (RI) detection instrument, the Optilab T-rEX. While RI detectors offer extreme sensitivity over a limited range and reduced sensitivity over a greater range, the T-rEX provides full range…
TRU | 22 July 2010
-
Big Pharma Struggles to Benefit from Increased CVD Drug Usage
Pharmaceutical (Pharma) companies will struggle to profit from the Cardiovascular Disease (CVD) market over the next decade despite growing drug usage, according to Datamonitor. It is predicted that the CVD pharma market will grow from US$99 billion …
TRU | 17 March 2010
-
Amsbio: HAMA Blocker for Reduction of Immunoassay Interference
Amsbio has introduced TRU Block, a potent reagent that actively blocks the Heterophilic Antibody (HA) interference in immunoassays including but not limited to Human Anti-Mouse Antibody (HAMA) interference. The reagent offers advantages over tradi…
TRU | 08 February 2010
-
China Aoxing Completes Menstrual Pain Drug Clinical Study
China Aoxing Pharmaceutical Company, a pharmaceutical company specializing in the research, development, manufacturing and distribution of narcotic and pain-management products, has announced that it completed a Phase II clinical study for oral TJSL …
TRU | 07 January 2010
-
PPD Launches Global Biostatistics Technology Infrastructure
PPD has launched a global information technology infrastructure for the analysis and reporting of clinical trial data. The Biostatistics Technology Infrastructure (BTI) is a centralized computing platform that enhances the company's ability to delive…
TRU | 10 December 2009
-
Symyx Introduces Chemistry Data Cartridge
Symyx Technologies has released the its Direct 6.3 chemistry data cartridge, which includes capabilities in the handling of non-specific Markush chemical structures. It enables researchers to register, search and retrieve molecular structures and…
TRU | 30 November 2009
-
ISPE Adjusts Online Learning Pricing Structure
The International Society for Pharmaceutical Engineering (ISPE) has modified the pricing structure of its Online Learning live and recorded webinars. “ISPE is sensitive to the fact that current economic conditions around the world make it diffi…
TRU | 12 November 2009
